Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment (Q85105275)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Radiotherapy: Intermediate-risk endometrial cancer--adjuvant treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Patricia J Eifel

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

1 October 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Clinical Oncology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

553-554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Pathology review and analysis of prognostic variables

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCLINONC.2010.138

Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20877416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20877416

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRCLINONC.2010.138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877416%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference